Top Institutions in Ophthalmology - Glaucoma and Drug Delivery
Institutions leading in this area typically have strong ophthalmology departments with dedicated glaucoma research programs, clinical trials in novel drug delivery systems, and collaborations with biomedical engineering for implant development. Expertise includes clinical evaluation of sustained-release implants, FDA trial leadership, and translational research in ocular pharmacology.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in glaucoma research and clinical trials, including pioneering work in sustained-release drug delivery systems and implantable devices. Their affiliation with Harvard Medical School supports cutting-edge translational research and FDA trial leadership.
Key Differentiators
- Ophthalmology
- Glaucoma
- Ocular Drug Delivery
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked among the top ophthalmology centers globally, with a robust glaucoma service and active involvement in clinical trials for novel glaucoma therapies including implantable drug delivery devices.
Key Differentiators
- Ophthalmology
- Glaucoma
- Drug Delivery Systems
-
#3
Wills Eye Hospital
Philadelphia, PA
Wills Eye Hospital has a long-standing reputation for excellence in glaucoma care and research, including participation in FDA trials for implantable glaucoma drug delivery systems and expertise in patient adherence challenges.
Key Differentiators
- Ophthalmology
- Glaucoma
- Clinical Trials
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its glaucoma research and innovation in ocular drug delivery, combining clinical expertise with biomedical engineering to develop and test new implantable devices.
Key Differentiators
- Ophthalmology
- Glaucoma
- Biomedical Research
-
#5
Duke University Eye Center
Durham, NC
Duke Eye Center has a growing glaucoma research program with focus on innovative drug delivery systems and patient adherence, contributing to multicenter clinical trials and translational research.
Key Differentiators
- Ophthalmology
- Glaucoma
- Clinical Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







